miR-4324 inhibits ovarian cancer progression by targeting FEN1

被引：0
|
作者：
Haixia Wu
Youliang Yan
Jialin Yuan
Mengze Luo
Yingjian Wang
机构：
[1] Pinghu Hospital,Department of Obstetrics and Gynecology
[2] Health Science Center,Department of Obstetrics and Gynecology
[3] Shenzhen University,undefined
[4] China-Japan Union Hospital of Jilin University,undefined
来源：
Journal of Ovarian Research | / 15卷
关键词：
miR-4324; FEN1; Ovarian cancer; Proliferation; Migration; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] miR-4324 inhibits ovarian cancer progression by targeting FEN1
    Wu, Haixia
    Yan, Youliang
    Yuan, Jialin
    Luo, Mengze
    Wang, Yingjian
    [J]. JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [2] RETRACTED: miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2 (Retracted Article)
    Li, Hailin
    Zhu, Guiling
    Xing, Yanwei
    Zhu, Yuekun
    Piao, Daxun
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019,
  • [3] Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
    Yang, Fan
    Hu, Zhigang
    Guo, Zhigang
    [J]. BIOMOLECULES, 2022, 12 (07)
  • [4] LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
    Yinling Zhao
    Donglan Yuan
    Dandan Zhu
    Tianhui Xu
    Aihua Huang
    Li Jiang
    Chiwen Liu
    Hua Qian
    Xinhua Bu
    [J]. Journal of Ovarian Research, 14
  • [5] Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
    Wang, Manman
    Xu, Zhengtan
    Cai, Qi
    Deng, Yanmei
    Shi, Weiqiao
    Zhou, Hongyu
    Wang, Dajiang
    Li, Jian
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [6] LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p
    Zhao, Yinling
    Yuan, Donglan
    Zhu, Dandan
    Xu, Tianhui
    Huang, Aihua
    Jiang, Li
    Liu, Chiwen
    Qian, Hua
    Bu, Xinhua
    [J]. JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [7] RETRACTION: miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2 (Retraction of Vol 48, art no 300060519883731, 2020)
    Li, H.
    Zhu, G.
    Xing, Y.
    Zhu, Y.
    Piao, D.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
  • [8] MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression
    Yao, Lijuan
    Wang, Li
    Li, Fengxia
    Gao, Xihai
    Wei, Xuegong
    Liu, Zhihui
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15198 - 15205
  • [9] FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1
    Berfelde, Johanna
    Hildebrand, Laura S.
    Kuhlmann, Lukas
    Fietkau, Rainer
    Distel, Luitpold V.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [10] FEN1 promotes cancer progression of cholangiocarcinoma by regulating the Wnt/ β-catenin signaling pathway
    Xie, Yuwei
    Dong, Bingzi
    Sun, Zhaowei
    Feng, Yujie
    Wei, Zhao
    Li, Kun
    Liu, Kui
    Cao, Jingyu
    Zhu, Chengzhan
    [J]. DIGESTIVE AND LIVER DISEASE, 2024, 56 (04) : 695 - 704
12345